Author:
Cassinelli Giuseppe,Torri Giangiacomo,Naggi Annamaria
Publisher
Springer International Publishing
Reference164 articles.
1. Bernfield, M., Götte, M., Park, P. W., et al. (1999). Functions of cell surface heparan sulfate proteoglycans. Annual Review of Biochemistry, 68, 729–777.
2. Hammond, E., Khurana, A., Shridhar, V., et al. (2014). The role of heparanase and sulfatases in the modification of heparan sulfate proteoglycans within the tumor microenvironment and opportunities for novel cancer therapeutics. Frontiers in Oncology, 4, 195.
3. Rivara, S., Milazzo, F. M., & Giannini, G. (2016). Heparanase: A rainbow pharmacological target associated to multiple pathologies including rare diseases. Future Medicinal Chemistry, 8, 647–680.
4. Irimura, T., Nakajima, M., & Nicolson, G. L. (1986). Chemically modified heparins as inhibitors of heparan sulfate specific endo-. Beta-glucuronidase (heparanase) of metastatic melanoma cells. Biochemistry, 25, 5322–5328.
5. Bitan, M., Mohsen, M., Levi, E., et al. (1995). Structural requirements for inhibition of melanoma lung colonization by heparanase inhibiting species of heparin. Israel Journal of Medical Sciences, 31, 106–118.
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献